Pharma
Why drugmakers and investors are pouring money into immunology
Analysts project the immunology market will be worth $257 billion by 2032.
Latest news and analysis on autoimmune disease treatments from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.